Haemophilia B mutations in Sweden: a population‐based study of mutational heterogeneity
Open Access
- 1 April 2001
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 113 (1) , 81-86
- https://doi.org/10.1046/j.1365-2141.2001.02759.x
Abstract
The present series comprises all families (n = 77) with haemophilia B in Sweden and may be considered to be representative for the purposes of a population‐based study of mutational heterogeneity. The 77 families (38 severe, 10 moderate, 29 mild) had 51 different mutations in total. Thirteen families had total, partial or small deletions, two had mutations in the promoter, eight families had splice site mutations, 14 had nonsense and the remaining 41 had missense mutations. Ten of the mutations, all C→T or G→A, recurred in 1–6 other families. Using haplotype analysis of seven polymorphisms in the factor IX (FIX) gene, we found that the 77 families carried 65 unique, independent mutations. Of the 48 families with severe or moderate haemophilia, 23 (48%) had a sporadic case of haemophilia compared with 31 families out of 78 (40%) in the whole series. Five of those 23 sporadic cases carried de novo mutations, 11 out of 23 of the mothers were proven carriers and, in the remaining seven families, it was not possible to determine carriership. Eleven of the 48 patients (23%) with severe haemophilia B developed inhibitors and all of them had deletions or nonsense mutations. Thus, 11 out of 37 (30%) patients with severe haemophilia B as a result of deletion/nonsense mutations developed inhibitors compared with 0 out of 11 patients with missense mutations. The ratio of male to female mutation rates was 5·3 and the overall mutation rate was 5·4 × 10−6 per gamete per generation.Keywords
This publication has 31 references indexed in Scilit:
- Mutation Rates in Humans. I. Overall and Sex-Specific Rates Obtained from a Population Study of Hemophilia BAmerican Journal of Human Genetics, 1999
- Gene Mutations and Inhibitor Formation in Patients with Hemophilia BActa Haematologica, 1995
- Origin of mutation in sporadic cases of haemophilia‐BEuropean Journal of Haematology, 1992
- Moderate haemophilia B in a female carrier caused by preferential inactivation of the paternal X chromosomeEuropean Journal of Haematology, 1991
- Evidence that descendants of three founders constitute about 25% of hemophilia B in the united statesGenomics, 1991
- DETECTION OF POLYMORPHISMS AT CYTOSINE PHOSPHOGUANADINE DINUCLEOTIDES AND DIAGNOSIS OF HAEMOPHILIA B CARRIERSThe Lancet, 1989
- Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)Biochemistry, 1985
- CHARACTERISATION AND USE OF AN INTRAGENIC POLYMORPHIC MARKER FOR DETECTION OF CARRIERS OF HAEMOPHILIA B (FACTOR IX DEFICIENCY)The Lancet, 1984
- Gene deletions in patients with haemophilia B and anti-factor IX antibodiesNature, 1983
- A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein SBiochemistry, 1977